Passage Bio to Present at Chardan’s 8th Annual Genetic Medicines Conference
Provided By GlobeNewswire
Last update: Sep 23, 2024
PHILADELPHIA, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (NASDAQ: PASG), a clinical stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases, today announced that Will Chou, M.D., president and chief executive officer, will present at Chardan’s 8th Annual Genetic Medicines Conference on Tuesday, October 1, 2024 at 8:30 a.m. ET.
0.33
+0 (+0.3%)
Find more stocks in the Stock Screener
PASG Latest News and Analysis
17 days ago - ChartmillThe market is filled with gapping stocks in Thursday's session.There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Thursday.
